PH

Patricia Hirano

Patricia Hirano


Senior VP



Professional Overview


Patricia Hirano is a seasoned life sciences executive with over 20 years of experience in regulatory affairs, strategic consulting, and biopharmaceutical operations. As the Senior VP at Soleno Therapeutics, Inc., she leverages her deep industry expertise to drive the company's regulatory and commercial strategies, ensuring the successful development and market introduction of innovative therapeutic solutions.

Experience Summary



Current Role


As the Senior VP at Soleno Therapeutics, Inc., Patricia is responsible for overseeing the company's regulatory affairs, quality assurance, and medical affairs functions. She plays a crucial role in navigating the complex regulatory landscape, securing key approvals, and establishing strategic partnerships to accelerate the commercialization of Soleno's pipeline of rare disease treatments. Under her leadership, the company has achieved several significant milestones, including the successful completion of pivotal clinical trials and the submission of multiple New Drug Applications.

Career Progression


Prior to her current role, Patricia served as the Vice President at Soleno Therapeutics, where she was instrumental in shaping the company's regulatory strategy and strengthening its relationships with key stakeholders. Before joining Soleno, she held various leadership positions, including Consultant at Regulatory Consultant, Director at Capnia, Inc., and Associate Director/Director of Regulatory Affairs at Titan Pharmaceuticals, Inc. Her diverse background in regulatory affairs, strategic consulting, and operational management has equipped her with a comprehensive understanding of the biopharmaceutical industry's challenges and best practices.

Academic Background


Patricia holds a Bachelor of Science degree in Biology from the University of California, Los Angeles, and a Master of Science degree in Regulatory Science from the University of Southern California. Her academic achievements, combined with her extensive industry experience, have made her a valuable asset to the organizations she has served.

Areas of Expertise


  • Regulatory affairs and quality assurance

  • Strategic planning and execution

  • Product development and commercialization

  • Stakeholder management and partnership building

  • Cross-functional team leadership and collaboration


Professional Impact


Throughout her career, Patricia has demonstrated a track record of driving positive outcomes for the organizations she has served. Her contributions have been instrumental in the successful development and approval of several innovative therapies, positively impacting the lives of patients and their families. As a recognized industry leader, Patricia is frequently invited to speak at industry events and has published numerous articles in peer-reviewed journals, sharing her insights and expertise with the broader biopharmaceutical community.

Conclusion


With her deep industry knowledge, proven leadership skills, and commitment to advancing the field of rare disease treatments, Patricia Hirano is poised to continue making a significant impact in her role as the Senior VP at Soleno Therapeutics, Inc. Her strategic vision, coupled with her ability to navigate complex regulatory landscapes, positions her as a valuable asset in the company's pursuit of delivering life-changing therapies to patients in need.